Visium Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-7,500
Closed -$1.15M 900
2015
Q2
$1.15M Sell
7,500
-1,760
-19% -$282K 0.02% 501
2015
Q1
$1.48M Buy
9,260
+5,310
+134% +$836K 0.02% 473
2014
Q4
$630K Sell
3,950
-207,235
-98% -$32.3M 0.01% 638
2014
Q3
$29.7M Buy
211,185
+209,025
+9,677% +$27.3M 0.44% 36
2014
Q2
$256K Buy
+2,160
New +$250K ﹤0.01% 922
2014
Q1
Sell
-67,806
Closed -$7.74M 859
2013
Q4
$7.74M Sell
67,806
-720,741
-91% -$82M 0.15% 129
2013
Q3
$88.3M Buy
788,547
+782,376
+12,678% +$84.8M 2% 9
2013
Q2
$609K Buy
+6,171
New +$640K 0.01% 441

Other funds holding AMGN

Visium Asset Management's AMGN Position: Q3 2015 in Review

Visium Asset Management sold out of Amgen (AMGN) in Q3 2015, closing a stake of 7,500 shares — an estimated $1.15M sold.

Visium Asset Management first reported a position in AMGN in Q2 2013 and held it in 8 quarters. The position peaked at $88.3M in Q3 2013. 1,381 funds tracked by Wall St. Rank hold AMGN as of Q3 2015.

  • Visium Asset Management reported no remaining Amgen position as of Q3 2015 after selling out during the quarter.
  • Visium Asset Management sold 7,500 Amgen shares in Q3 2015, an estimated $1.15M.
  • Visium Asset Management first reported a position in Amgen in Q2 2013 and held it in 8 quarters.
  • Visium Asset Management's Amgen position peaked at $88.3M in Q3 2013.
  • 1,381 funds tracked by Wall St. Rank held Amgen as of Q3 2015.

Based on Visium Asset Management's 13F filing for Q3 2015, filed 16 Nov 2015.